Differentiation and patterning in the developing nervous system require the vitamin A metabolite all-trans-retinoic acid (atRA). Recent data suggest that higher cognitive functions, such as creation of hippocampal memory, also require atRA and its receptors, RAR, through affecting synaptic plasticity. Here we show that within 30 min atRA increased dendritic growth ϳ2-fold, and PSD-95 and synaptophysin puncta intensity ϳ3-fold, in cultured mouse hippocampal neurons, suggesting increased synapse formation. atRA (10 nM) increased ERK1/2 phosphorylation within 10 min. In synaptoneurosomes, atRA rapidly increased phosphorylation of ERK1/2, its target 4E-BP, and p70S6K, and its substrate, ribosome protein S6, indicating activation of MAPK and mammalian target of rapamycin (mTOR). Immunofluoresence revealed intense dendritic expression of RAR␣ in the mouse hippocampus and localization of RAR␣ on the surfaces of primary cultures of hippocampal neurons, with bright puncta along soma and neurites. Surface biotinylation confirmed the locus of RAR␣ expression. Knockdown of RAR␣ by shRNA impaired atRA-induced spine formation and abolished dendritic growth. Prolonged atRA stimulation reduced surface/total RAR␣ by 43%, suggesting internalization, whereas brain-derived nerve growth factor or bicuculline increased the ratio by ϳ1.8-fold. atRA increased translation in the somatodendritic compartment, similar to brain-derived nerve growth factor. atRA specifically increased dendritic translation and surface expression of the ␣-amino-3-hydroxyl-5-methyl-4-isoxazole propionate receptor (AMPAR) subunit 1 (GluR1), without affecting GluR2. These data provide mechanistic insight into atRA function in the hippocampus and identify a unique membrane-associated RAR␣ that mediates rapid induction of neuronal translation by atRA.-Chen, N., Napoli, J. L. All-transretinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membraneassociated RAR␣. FASEB J. 22, 236 -245 (2008) 
differentiation and functions of many cell types, including epithelial, immune, and nerve cells (2) (3) (4) (5) . Nervous system development depends on atRA for patterning of the hindbrain anterior/posterior axis and the spinal cord dorsal/ventral axis, and interneuron and motor neuron specification (6) . In neural crest cells, embryonic stem cells, and established neuronal cell lines (e.g., PC12, Ntera2), atRA induces differentiation into region-specific central or peripheral nervous system progeny (6, 7) . Members of the nuclear receptor family, RAR␣, ␤, and ␥, mediate atRA action (8) . The distinct RAR subtypes have been associated with distinct, but sometimes overlapping, retinoid functions (8, 9) . The liganded receptors are best known for their ability to bind to response elements in the promoters of target genes and induce transcription.
The developed nervous system also relies on atRA signaling, notably in synaptic plasticity that underlies hippocampus-dependent spatial learning and memory. RAR␤-null mice exhibit severely compromised performance in the Morris water maze, an assessment of spatial learning (10) . Rats and mice restricted in dietary vitamin A make markedly more errors than controls in the radial arm maze, another measurement of hippocampus-dependent learning (11) . Replenishing dietary vitamin A reverses the defects in rats and attenuates the defects in mice. Retinoid effects on learning and memory extend to aged mice. Compared with younger adult mice (4 -5 months), aged mice (21-23 months) exhibit relational memory deficits, also reversible by atRA dosing (12) . Long-lasting, activity-dependent changes in synaptic efficacy, i.e., long-term potentiation (LTP) and long-term depression (LTD), provide leading cellular mechanisms for learning and memory (13) . Vitamin A deprivation in adult mice reduces LTP and abolishes LTD in the hippocampus (14) . Acute treatment of vitamin A-depleted hippocampal slices with atRA rescues these defects. Little or no insight, however, has been forthcoming into mechanism(s) of these atRA effects.
Dendritic spines provide contact sites for most exci- tatory synaptic inputs in the brain (15) . Spines are thought to derive from filopodia, slender, highly motile, headless structures prevalent early in development (16 -18) . Quantitative and ultrastructure analysis of spines and filopodia in developing hippocampal neurons suggest that dendritic filopodia serve as the direct precursors to spines (18) . Time-lapse images support this conclusion, revealing that dendritic filopodia make iterative contacts with axons en passant, followed by formation of synaptic boutons and addition of pre-and postsynaptic proteins, culminating in synaptogenesis (16, 19 -22) . Activity dynamically shapes spines. Induction of LTP stimulates formation and enlargement of spines, whereas induction of LTD causes spine shrinkage and elimination (23) (24) (25) (26) . Stimulation of the N-methyl-Daspartate receptor (NMDAR) leads to growth of spinelike protrusions from dendrites (26, 27) , whereas activation of AMPAR inhibits spine motility, producing more regular and stable spines (28) . AMPAR activity also maintains spines. Blocking AMPAR activity with botulinum toxin A or C, which blocks vesicular glutamate release, markedly reduces spines (29) . Thus, NMDAR activation initiates spine dynamics, followed by AMPAR-dependent stabilization and maintenance.
Enduring modification of synaptic strength often involves changes in the postsynaptic AMPAR content (30 -2) . Activity bidirectionally regulates transport of mRNA to dendrites that encode the AMPAR subunits GluR1 and GluR2 (33) . These mRNA undergo dendritic translation, followed by incorporation of the translated AMPAR subunits into the synaptic membrane (34) . Distinct regulation of dendritic GluR1 and GluR2 synthesis facilitates AMPAR recomposition, which underlies various forms of plasticity. For example, activation of the dopamine receptor induces a rapid form of synaptic enhancement, mediated by an increase in dendritic GluR1 translation (35) . During homeostatic scaling, a form of plasticity elicited by chronic activity blockade, GluR1 undergoes translation locally and incorporation into the synaptic membrane, followed by gradual replacement with GluR2-containing AMPARs (36) .
Here we report that atRA signaling contributes to spine formation in hippocampal neurons and does so through an unconventional mechanism for retinoids. This effect relies on an RAR␣ unexpectedly targeted to the neuronal membrane. Furthermore, we show that atRA function through RAR␣ modifies translation, but not transcription, leading to an increase of GluR1 in the synaptic compartment.
MATERIALS AND METHODS

Cultures and transfections
Hippocampal neurons were dissected from E17-18 C57/ Black 6 mouse embryos, and cultured in DMEM with 10% FBS on plates or glass cover slips precoated with poly-D-Lysine (Sigma, St. Louis, MO, USA). Neurons were plated in 24-well (1ϫ10 5 cells/well) or 6-well (5ϫ10 5 cells/well) plates. Four hours after initial culture, the medium was replaced with neurobasal medium containing 2% B27 supplement (Invitrogen, Carlsbad, CA, USA). Half of the medium was replenished each week. After 1 wk culture, 2 M Ara C (Sigma) was added to prevent glia proliferation. 
Surface biotinylation
Neurons were rinsed with progressively cooler (room temperature, 10°C and 4°C) PBS containing 1 mM MgCl 2 and 2.5 mM CaCl 2 , followed by incubation with 1.5 mg/ml sulfo-NHSbiotin reagent (Pierce, Rockford, IL, USA) in PBS for 15 min at 4°C. Unreacted biotin was quenched with cold 50 mM glycine (Sigma) in PBS. Cells were scrapped into modified RIPA buffer with 0.5% Triton X-100, sonicated, and centrifuged at 12,000 g for 10 min. The supernatant was incubated for 1 h at room temperature with Streptavidin MagneSphere beads (Promega, Madison, WI, USA). MagneSphere beads were isolated with a magnetic stand (Qiagen, Valencia, CA, USA) and washed with RIPA buffer 3 times. Bound proteins were eluted with Laemmli buffer (Bio-Rad, Hercules, CA, USA).
mRNA reporter, RAR␣ siRNA, and shRNA constructs A reporter mRNA template was generated by PCR amplification of a 160 nt fragment of the CaMKII ␣ 3Ј-UTR distal region, which confers translation regulation (37) , from mouse brain cDNA, and the EGFP-coding region from pEGFP-N1 plasmid (Clontech, Mountain View, CA, USA), both of which were ligated into pBluescript (Promega) for transcription in vitro with T7 Message Machine (Ambion, Austin, TX, USA). The reporter mRNA was transfected into DIV10 neurons with transmessenger reagent (Qiagen, Valencia, CA, USA) following manufacturer's protocol. atRA (1 M) and BDNF (100 ng/ml in H 2 O) were added immediately after transfection. EGFP-positive neurons were scored 18 h after treatment in 5 randomly selected panels from at least 3 coverslips per experiment. Experiments were repeated 3 times, and the data were pooled. The siRNA duplexes were purchased from Dharmacon (Lafayette, CO, USA) or Santa Cruz Biotech. siRNA was transfected into HEK or neurons with Lipofectamine 2000 (Invitrogen) or Transmessenger (Qiagen). The RAR␣ shRNA sequence was designed based on published guidelines (38): 5Ј-AAGCCTTGCTTTATTTGTCAGTACAAATATTCATTG-TATTGACAAACAAAGCAAGGCTT-3Ј. Oligos were annealed and cloned into pSuppressor-Neo (Imgenex, San Diego, CA, USA) to produce pSuppressor-Neo-RAR␣ shRNA. The shRNA plasmids were cotransfected with pEGFP-N1 (Clontech) using Lipofectamine 2000 (Invitrogen). Firefly luciferase siRNA or shRNA was used as control. Analyses of siRNA and shRNA effects were done 48 h after transfection.
Synaptoneurosomes and immunoblots
Synaptoneurosomes were prepared from 1-month-old C57/ Black 6 mice as described (39) . Purity was verified by immunoblotting for GFAP (glia marker), laminin (a nuclear protein), PSD-95 and synaptophysin (synaptic proteins). Isolated synaptoneurosomes were kept in a 37°C incubator for at least 10 min before treatment. After atRA (1 M) treatment, synaptoneurosomes were solubilized with SDS sample buffer (2% SDS in 50 mM Tris-HCl, pH 7.5) preheated to 95°C and were subjected to 4 -15% gradient SDS-PAGE. Proteins were transferred onto a nitrocellulose membrane and blotted with phosphorylated ERK1/2 (1:2000), p70S6K, S6, or 4EBP (1: 1000, Millipore) Ab, or GluR1 (1:2000, Millipore, Billerica, MA, USA), GluR2 (1:2000, Invitrogen, Carlsbad, CA, USA), PSD-95 (1:2000, Affinity Bioreagents), Tuj1, transferrin receptor, and total ERK1/2 (1:2000, Millipore) Ab for 3 h at room temperature or overnight at 4°C. Blots were washed with PBST, incubated with secondary Ab for 1 h at room temperature, and developed with SuperSignal West Pico Chemoluminescent Kit (Pierce, Rockford, IL, USA). Signals were quantified with densitometry. Immunoblot experiments were repeated at least three times. For experiments that examined pERK1/2, surface/total RAR␣, and synaptoneurosome or surface/total GluR1, band intensities, and surface/ total ratios from the vehicle-treated controls were assigned a value of 1. Band intensities and ratios of the treated groups were expressed relative to the controls and averaged.
Image acquisition and quantification
Z-stacked images were acquired on a Zeiss LSM 510 laser scanning confocal microscope. Each experiment was repeated 3 to 5 times. Neuronal images for analysis were selected randomly and quantified by an investigator blind to the treatments. For analysis of dendritic spines, z-stacks were acquired with a ϫ63 (N.A. 1.4) oil immersion Plan-Apochromat objective with a ϫ2 digital zoom (or ϫ4 digital zoom for higher magnification). To count spines or to quantify fluorescent signals, two to three 100 m segments were chosen from dendrites of similar calibers in each cell: 8 -10 neurons were analyzed for each condition. Spines in blinded samples were traced manually and counted. The data were normalized to 10 m of dendrites. We used customized MATLAB 6.5 software to quantify immunofluorescent intensity. Individual density and intensity measurements were grouped and averaged per neuron. Means from different neurons were then averaged. Live imaging was done in neurobasal medium supplemented with 10 mM HEPES. Inhibitor treatment began 10 to 30 min before atRA (1 M) addition. Quantification of dendritic growth after atRA dosing included filopodia, defined as headless dendritic protrusions 0.5-3 m long.
Statistics
Statistical differences were calculated using an unpaired, twotailed Student's t test, except for the experiment examining the atRA effect on control or RAR␣ knockdown neurons, where we used two-way ANOVA. Data in bar graphs represent means Ϯ sem.
RESULTS
atRA induces dendritic growth rapidly atRA induced a 2-fold increase in dendritic protrusions (3.2Ϯ0.6 vs. 6.7Ϯ0.9, PϽ0.0001, nϭ10 neurons), including spines (defined as Ͻ0.5 m dendritic protrusions with rounded heads at least twice the diameter of the neck) and filopodia (defined as headless dendritic protrusions 0.5-3 m long) in cultured mouse hippocampal neurons by 30 min (Fig. 1A) . Filopodia seem to function as explorative precursors for dendritic spine and synapse formation (16 -18, 40, 41) . To test for synapse formation, we fixed neurons immediately after atRA treatment and stained them with the synaptic markers PSD-95 (a scaffold protein at the postsynaptic density) or synaptophysin (a presynaptic vesicle protein) (42) . We costained cells with phalloidin, which binds specifically to filamentous actin (F-actin), and an antimicrotubule associated protein 2 (MAP2) Ab, to visualize the cytoskeleton (Fig. 1B) . Phalloidin staining demonstrated that atRA induced expansion (thickening) of F-actin, in contrast to the unaltered microtubules revealed by MAP2 staining. atRA increased the fluorescence intensity of PSD-95 and synaptophysin ϳ3-fold, suggesting an increase in the number of synapses (Fig. 1B) . Notably, PSD95 and synaptophysin puncta occurred along the length, and often at the tips of the extended actin bundles. These results indicated that atRA induces spine formation and possibly initiates synapse formation within 30 min.
We imaged EGFP-expressing neurons exposed to atRA in the presence of inhibitors to gain insight into the mechanism of this rapid effect. Within 10 min, atRA induced an average growth of 1.5 Ϯ 0.05 protrusions per 10 m dendrite, n ϭ 5 (Fig. 1C, D) . At this time, most atRA-induced growth was filopodia-like. The MEK inhibitor U0126, the Ras inhibitor AGGC, and the actin depolymerization drug cytochalasin D, each prevented dendritic growth, whereas the protein kinase A inhibitor KT5720 had no effect. These results suggest involvement of the Ras-MAPK pathway and actin remodeling in atRA-induced dendritic growth.
The rapid onset of atRA action, and the impact of Ras-MEK inhibitors, suggested a nontranscriptional mechanism involving MAPK signaling. MAPK activation induces cytoskeletal rearrangement and dendritic translation in hippocampal neurons, producing persistent dendritic growth (43, 44) , and atRA stimulates the MAPK pathway in non-neuronal cells (45, 46) . Therefore, we probed atRA activation of MAPK with phos-phorylated ERK1/2 Ab. Within 10 min, atRA increased phosphorylation of ERK1/2 in a dose-dependent manner (Fig. 1E) , without altering total ERK1/2. Activation subsided after prolonged atRA treatment (Fig. 1F) . These data indicate that MAPK activation underlies atRA-induced structural growth. 
RAR␣ localizes to the neuronal membrane
Immunostaining of cryosections from the mouse hippocampus revealed that the dendritic region expressed RAR␣ intensely, whereas somatic and axonal expression occurred to a much lesser extent ( Fig. 2A) . In contrast, RAR␤ expression concentrated in the cell soma. We did not detect RAR␥ (47) . Dendritic localization of RAR␣ and nuclear localization of RAR␤ were confirmed in cultured neurons (data not shown). This unexpected dendritic expression suggests that RAR␣ may mediate the rapid atRA-induced signaling.
Some nuclear receptors localize to the plasma membrane or the endoplasmic reticulum, and transduce nongenomic ligand signaling (48 -50) . To test for localization of RAR␣ in the plasma membrane, we biotinylated the surface proteins from cultured neurons and isolated the biotinylated fraction with streptavidin beads. Immunoblots demonstrated the presence of RAR␣ and the membrane receptor GluR2, but not the intracellular protein Tuj1 in the surface fraction (streptavidin pull-down) (Fig. 2B) . Ab staining of live neurons confirmed the surface expression of RAR␣ (Fig. 2C) . Two different RAR␣ Ab each labeled bright puncta along the cell soma and neurites, similar to those observed for GluR2. The Ab to an abundant cytoplasmic protein, calcium-calmodulin dependent protein kinase II ␣ (CaMKII ␣), produced no signal in sister cultures, validating cell membrane integrity. Immunostaining of fixed and nonpermeabilized cells yielded similar results (data not shown). Significantly, atRA reduced the ratio of surface to total RAR␣ by 43%, indicating ligand-induced endocytosis (Fig. 2D) . Stimulating neurons with brain-derived nerve growth factor (BDNF) or bicuculline, a GABA-receptor antagonist, each increased the ratio of surface to total RAR␣ by ϳ1.8-fold, whereas blocking action potential with tetrodotoxin (TTX) had no marked effect (Fig. 2E) . Taken together, these results demonstrate the ligand-and activity-dependent regulation of a distinct pool of RAR␣ on the neuronal surface.
RAR␣ mediates atRA-dependent spine formation
We used siRNA to assess the contribution of RAR␣ to atRA-induced spine formation. Because siRNA generally transfects more efficiently than plasmids (data not shown) and may affect nearby non-EGFP-expressing neurons, we also designed a Pol III-driven RAR␣-specific small hairpin RNA (shRNA) expression cassette to ensure that knockdown occurred only in EGFP-expressing cells. Both siRNA and shRNA eliminated expression of a cotransfected EGFP-RAR␣ fusion protein in HEK293 cells and COS cells, without affecting ␤-actin, verifying their specificities (Fig. 3A) . Neurons transfected with RAR␣ siRNA and shRNA had 60% and 70% fewer spines, respectively (Fig.  3B) . Notably, atRA increased dendritic protrusions in control shRNA-transfected, but not RAR␣ shRNA-transfected neurons (Fig. 3C) . These data indicate that RAR␣ mediates atRA signaling in hippocampal neurons to promote spine formation. 
atRA induces neuronal translation
Rapid activation of MAPK and the contribution of MAPK to neuronal translation suggest a mechanism of atRA action (37, 51) . To test whether atRA induces translation, we transfected neurons with an mRNA encoding a EGFP reporter appended with a 160-bp segment of CaMKII ␣ 3Ј-UTR, which confers translational regulation, as used previously to probe translation regulation by MAPK in neurons (37) . atRA increased the number of EGFP-positive cells Ͼ2-fold (Fig.  4A, B) , similar to the effects of BDNF, a translation stimulator (37) . The translation inhibitor anisomycin, but not the transcription inhibitor actinomycin, prevented the increase in EGFP expression, confirming an atRA effect on translation. To test whether atRA affected mRNA stability, we transfected neurons with CaMKII Ϫ3ЈUTR-GFP mRNA, treated them with DMSO or atRA, and used real-time PCR to quantify the amount of RNA after treatment. There was no difference in reporter mRNA levels normalized to ␤-actin between the two groups: GluR1/␤-actin of DMSO (0.65Ϯ0.16) vs. RA-treated (0.63Ϯ0.05), mean Ϯ sem, n ϭ 3.
In addition, rapid MAPK activation (ERK1/2) was observed in synaptoneurosomes, with a concomitant increase in phosphorylation of its target, eIF4E binding protein 4E-BP (Fig. 4C) . Brief atRA treatment also increased phosphorylation of p70S6K and its substrate, ribosome protein S6, indicating activation of mammalian target of rapamycin (mTOR), which acts upstream of p70S6K. MAPK and mTOR regulate cap-dependent translation and 5Ј-oligopyrimidine tract-containing ribosomal protein and translation factor synthesis (51). These results suggest that atRA increases general translation efficiency and capacity in the somatodendritic compartment.
atRA increases surface expression and dendritic translation of GluR1
Next, we sought to identify targets of atRA-stimulated translation. Glutamate receptors (GluR1 and GluR2) and synaptic scaffold protein PSD-95 can be translated locally in dendrites (33, 34, (52) (53) (54) . In synaptoneurosomes. atRA treatment induced a small (25%) but consistent increase in GluR1 (Fig. 5A) , without changing GluR2 or PSD-95 expression. The translation inhibitor cycloheximide prevented the atRA-induced increase in GluR1, confirming translational regulation. The proteasome inhibitor, MG132, raised the GluR1 steady-state level by 2-fold, obscuring the small increase in GluR1 induced by atRA. Consistent with this, cycloheximide treatment did not change basal or MG132-enhanced GluR1, indicating a quantitatively minor contribution of newly translated GluR1 to the steady-state pool.
Thirty-five to forty percent of newly synthesized AM-PAR move to the dendritic membrane, where they await activity-dependent synaptic recruitment (34, 55, 56) . Activation of synaptic AMPAR stabilizes actin and maintains spines (28, 29) . Enhancement of dendritic GluR1 synthesis by atRA, and the specific requirement of GluR1 in synaptic AMPAR expression (13, 57) , suggest that atRA-induced spine formation may involve an increase in surface AMPAR. Indeed, surface biotinylation demonstrated that atRA elevated the ratio of surface to total GluR1 by 50% within 15 to 30 min (Fig.  5B) , without affecting the ratios surface/total GluR2 or transferrin receptor. These results indicate that atRA specifically modulates dendritic synthesis and surface expression of GluR1.
DISCUSSION
atRA has been used widely to induce differentiation of stem cells into neurons and glia (58, 59) . In vivo, atRA promotes differentiation and survival of adult neural stem cells in the hippocampal dentate gyrus and controls the number, timing, and subtype of motor neurons produced in the spinal cord (60) . These effects require prolonged atRA exposure and seem to rely on transcription. Here, we have demonstrated nontranscriptional atRA signaling in relatively differentiated neurons. The observations of a membrane-associated RAR␣ and atRA-induced translation were unexpected, because the prevailing insight into atRA and RAR action has centered on transcription (7, 10, 61) , and the initial association between atRA and synaptic plasticity was made in the RAR␤-null mouse (10) .
atRA acts through several mechanisms to promote spine formation (Fig. 6) . First, atRA initiates actin dynamics, evident by rapid filopodia growth. Dendritic growth occurs almost immediately (less than 5 min) after atRA stimulation and may serve as the platform for later atRA-dependent modifications. Second, atRA enhances dendritic translation, indicated by activated MAPK and mTOR signaling, major regulatory pathways of neuronal translation (51) , and increased expression of a reporter bearing a CaMKII ␣ mRNA regulatory element. Dendritic protein synthesis and growth mechanisms interact to implement persistent structure and synaptic modification (62) (63) (64) . atRA-induced translation may maintain initial structural growth. Consistent with this, translation inhibition by anisomycin nearly abolished atRA-induced spine formation (data not shown). Third, atRA increases dendritic translation and surface expression of GluR1. GluR1 insertion is required for activity-driven AMPAR trafficking to the synapse and involves two steps: activity-independent extrasynaptic insertion and activity-dependent synaptic recruitment/stabilization (54, 57, 65) . The atRA-dependent increase in surface GluR1 occurs in the presence of the NMDAR antagonist DL-2-amino-5-phosphonovaleric acid (data not shown), suggesting that insertion occurs extrasynaptically and independent of synaptic NMDAR activation. Locally synthesized GluR1 readily incorporates into the dendritic membrane and may contribute to the synaptic AMPAR recomposition that supports synaptic plasticity (35, 36) . Therefore, atRA-induced GluR1 translation and membrane targeting may prime activity-dependent synaptic recruitment of AMPAR. Synaptic AMPAR activity would in turn stabilize actin and transform atRA-induced growth into persistent spines (28, 29) .
Administration of atRA to aged mice enhanced LTP of hippocampal CA1 synapses, which generally expresses as postsynaptic enhancement of the AMPAR response (13) . atRA could facilitate LTP expression by enriching extrasynaptic GluR1 and/or by augmenting basal dendritic translation. Consistent with these notions, expanding the extrasynaptic pool of GluR1 through forskolin/rolipram-induced PKA activation primed LTP expression (66) , and mice lacking the translation initiation inhibitors 4E-BP2 or GCN2 had enhanced basal translation and a lowered threshold for LTP induction (67, 68) . The effect of atRA on protein synthesis may explain the bidirectional defects in both LTP and LTD expression in vitamin A-depleted mice (14) , because early expression of LTP and LTD can require new protein synthesis (69 -72) . Therefore, atRA seems to function as a neuromodulator that facilitates expression of bidirectional synaptic plasticity.
RAR␣ likely serves as the principle mediator of nongenomic atRA effects on spine formation, because knockdown of RAR␣ blunted the response to atRA and reduced spine numbers. Loss of surface RAR␣ followed the onset of atRA signaling closely, possibly terminating signals through ligand-induced internalization. Notably, we observed attenuation of MAPK and a plateau of mTOR signaling after 30 min of atRA stimulation, a time of greatly reduced surface RAR␣. Neuronal activity, stimulated by BDNF or bicuculline (Fig. 2E) , also modulated the surface expression of RAR␣, suggesting an RAR␣ contribution to activity-dependent structure rearrangement. These actions of atRA and RAR␣ have features in common with estrogen and ER␣. Brief exposure to estradiol induces signaling cascades dependent on the cell type, including Ras (73), Raf-1 (73), ERK1/2 (73, 74), PKA (75) , and PKC (75, 76) and initiates cytoskeletal reorganization, such as formation of membrane raffles and pseudopodia (49) . These nongenomic effects require a membrane-resident ER␣ that associates with other membrane receptors (e.g., G-protein G␣13) (49) or adaptor molecules (e.g., the Src homology and collagen homology adaptor protein shc) (77) . Likely, membrane RAR␣ also interacts with unique partners: we are currently addressing this issue.
atRA concentrations in the hippocampus are among the highest in the brain (76) . Both astrocytes and neurons convert the serum-borne precursor retinol into atRA (4) . Astrocytes express Stra6, the receptor for serum retinol binding-protein (rbp4), and therefore should concentrate serum retinol (78, 79) . Hippocampal astrocytes have a higher rate of atRA biosynthesis than neurons and export most of their atRA into the medium (Wang and Napoli, unpublished observations). In the CNS, glia cells associate intimately with the neuronal synapse and secrete signaling molecules that modulate synaptic development and function (80, 81) . Therefore, astrocytes may provide atRA for membrane-localized neuronal RAR␣. In contrast, neurons tend to retain the atRA they biosynthesize. In contrast to an earlier report that RAR␤ cannot be detected in the hippocampus (47), we have detected RAR␤ constitutively in the nuclei of hippocampal neurons. Our observation is consistent with the hippocampal plasticity defects in RAR␤-null mice (10) . We suspect that intracellular neuronal atRA biosynthesis may provide ligand for activating nuclear RAR␤. These two different potential sources of atRA would provide opportunity for differential atRA delivery and signaling. atRA/RAR␣ initiates actin remodeling and dendritic translation through activation of the Ras-MAPK and mTOR pathways. In addition, atRA/RAR␣ increases dendritic translation and surface expression of GluR1, priming an increase in synaptic GluR1, and therefore AMPAR, expression. Synaptic AMPAR activity in turn would stabilize actin dynamics and consolidate atRA-induced spines. Dendritic synthesis of other proteins induced by atRA also may contribute to spine formation.
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